193 related articles for article (PubMed ID: 28926841)
21. Interactions between angiotensin AT1 receptor antagonists and second-generation antiepileptic drugs in the test of maximal electroshock.
Łukawski K; Janowska A; Jakubus T; Czuczwar SJ
Fundam Clin Pharmacol; 2014 Jun; 28(3):277-83. PubMed ID: 23551463
[TBL] [Abstract][Full Text] [Related]
22. Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Dudra-Jastrzebska M; Andres-Mach M; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):18-25. PubMed ID: 19751793
[TBL] [Abstract][Full Text] [Related]
23. Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis.
Luszczki JJ; Czuczwar SJ
Eur Neuropsychopharmacol; 2005 Mar; 15(2):133-42. PubMed ID: 15695057
[TBL] [Abstract][Full Text] [Related]
24. Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis.
Luszczki JJ; Czuczwar SJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):51-64. PubMed ID: 16972063
[TBL] [Abstract][Full Text] [Related]
25. Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):169-81. PubMed ID: 16604339
[TBL] [Abstract][Full Text] [Related]
26. P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity.
Zhou P; Zhang Y; Xu H; Chen F; Chen X; Li X; Pi X; Wang L; Zhan L; Nan F; Gao Z
Mol Pharmacol; 2015 Jan; 87(1):31-8. PubMed ID: 25319542
[TBL] [Abstract][Full Text] [Related]
27. Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model--an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar SJ
Eur J Pharmacol; 2005 May; 515(1-3):54-61. PubMed ID: 15894310
[TBL] [Abstract][Full Text] [Related]
28. Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.
Luszczki JJ; Czuczwar M; Kis J; Krysa J; Pasztelan I; Swiader M; Czuczwar SJ
Epilepsia; 2003 Aug; 44(8):1003-13. PubMed ID: 12887431
[TBL] [Abstract][Full Text] [Related]
29. Retigabine: fewer drug interactions.
Prescrire Int; 2012 Mar; 21(125):61. PubMed ID: 22428181
[TBL] [Abstract][Full Text] [Related]
30. Isobolographic and behavioral characterizations of interactions between vigabatrin and gabapentin in two experimental models of epilepsy.
Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Eur J Pharmacol; 2008 Oct; 595(1-3):13-21. PubMed ID: 18708046
[TBL] [Abstract][Full Text] [Related]
31. Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: a type II isobolographic analysis.
Luszczki JJ; Filip D; Florek-Luszczki M
Epilepsy Res; 2012 Feb; 98(2-3):148-56. PubMed ID: 21944895
[TBL] [Abstract][Full Text] [Related]
32. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.
Luszczki JJ; Borowicz KK; Swiader M; Czuczwar SJ
Epilepsia; 2003 Apr; 44(4):489-99. PubMed ID: 12680997
[TBL] [Abstract][Full Text] [Related]
33. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
[TBL] [Abstract][Full Text] [Related]
34. Anticonvulsant and neurotoxic effects of a novel 1,2,4-triazole-3-thione derivative (TPF-34) and its isobolographic interaction profile with classical antiepileptic drugs in mice.
Łuszczki JJ; Lepiech J; Zagaja M; Wróblewska-Łuczka P; Florek-Łuszczki M; Bojar H; Walczak A; Plech T
Pharmacol Rep; 2020 Feb; 72(1):87-95. PubMed ID: 32016835
[TBL] [Abstract][Full Text] [Related]
35. Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Sawicka KM; Załuska K; Wawryniuk A; Załuska-Patel K; Szczyrek M; Drop B; Daniluk J; Szpringer M; Żółkowska D; Łuszczki JJ
Epilepsy Res; 2017 Jul; 133():67-70. PubMed ID: 28458102
[TBL] [Abstract][Full Text] [Related]
36. Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves.
Luszczki JJ; Filip D; Czuczwar SJ
Epilepsy Res; 2010 Oct; 91(2-3):166-75. PubMed ID: 20692123
[TBL] [Abstract][Full Text] [Related]
37. Lamotrigine and retigabine increase motor threshold in transcranial magnetic stimulation at the dose required to produce an antiepileptic effect against maximal electroshock-induced seizure in rats.
Hotta N; Miyamoto M; Suzuki K
Neurosci Lett; 2022 Feb; 771():136460. PubMed ID: 35051437
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Patsalos PN; Berry DJ
Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Tompson DJ; Crean CS; Reeve R; Berry NS
Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
[TBL] [Abstract][Full Text] [Related]
40. Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Sawicka KM; Florek-Łuszczki M; Wawryniuk A; Daniluk J; Wróblewska-Łuczka P; Chmielewski J; Karwan S; Łuszczki JJ
Epilepsy Res; 2019 Aug; 154():62-68. PubMed ID: 31059963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
